SIBN Stock Overview
A medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
SI-BONE, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$12.15 |
52 Week High | US$21.70 |
52 Week Low | US$11.76 |
Beta | 1.23 |
11 Month Change | -6.39% |
3 Month Change | -26.59% |
1 Year Change | -32.24% |
33 Year Change | -42.25% |
5 Year Change | -31.47% |
Change since IPO | -39.43% |
Recent News & Updates
Market Cool On SI-BONE, Inc.'s (NASDAQ:SIBN) Revenues
Nov 04Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?
Sep 25Recent updates
Market Cool On SI-BONE, Inc.'s (NASDAQ:SIBN) Revenues
Nov 04Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?
Sep 25SI-BONE, Inc.'s (NASDAQ:SIBN) P/S Is On The Mark
Apr 01Analyst Estimates: Here's What Brokers Think Of SI-BONE, Inc. (NASDAQ:SIBN) After Its Full-Year Report
Feb 29Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?
Feb 28Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?
Nov 12Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?
Aug 09Is SI-BONE (NASDAQ:SIBN) A Risky Investment?
Apr 20Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?
Jan 01Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?
Sep 24SI-BONE (NASDAQ:SIBN) Has Debt But No Earnings; Should You Worry?
Apr 19Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?
Jan 05Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?
Oct 05Shareholder Returns
SIBN | US Medical Equipment | US Market | |
---|---|---|---|
7D | -2.3% | -0.4% | -1.0% |
1Y | -32.2% | 20.3% | 30.3% |
Return vs Industry: SIBN underperformed the US Medical Equipment industry which returned 20.9% over the past year.
Return vs Market: SIBN underperformed the US Market which returned 30.4% over the past year.
Price Volatility
SIBN volatility | |
---|---|
SIBN Average Weekly Movement | 9.4% |
Medical Equipment Industry Average Movement | 8.2% |
Market Average Movement | 6.2% |
10% most volatile stocks in US Market | 15.7% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SIBN has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: SIBN's weekly volatility (9%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | 344 | Laura Francis | si-bone.com |
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion.
SI-BONE, Inc. Fundamentals Summary
SIBN fundamental statistics | |
---|---|
Market cap | US$509.55m |
Earnings (TTM) | -US$37.40m |
Revenue (TTM) | US$157.04m |
3.2x
P/S Ratio-13.6x
P/E RatioIs SIBN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SIBN income statement (TTM) | |
---|---|
Revenue | US$157.04m |
Cost of Revenue | US$35.02m |
Gross Profit | US$122.02m |
Other Expenses | US$159.42m |
Earnings | -US$37.40m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.89 |
Gross Margin | 77.70% |
Net Profit Margin | -23.82% |
Debt/Equity Ratio | 21.9% |
How did SIBN perform over the long term?
See historical performance and comparison